73 - HIV PrEP Updates

Thursday, October 20, 2022

1:45 PM – 3:00 PM US ET

Location: 207 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Colleen Kelley, MD, MPH (she/her/hers)

Associate Professor of Medicine
Emory University
Decatur, GA, United States

Disclosure(s): Gilead Biosciences: Grant/Research Support (Ongoing); Humanigen: Grant/Research Support (Ongoing); Moderna, Inc.: Grant/Research Support (Ongoing); Novavax, Inc.: Grant/Research Support (Ongoing); Viiv Healthcare: Grant/Research Support (Ongoing)
Valeria Cantos, M.D

Assistant Professor
Emory University School of Medicine
Atlanta, GA, United States

Disclosure(s): No financial relationships to disclose

Faculty(s)

Rupa Patel, MD MPH (she/her/hers)

Research Associate Professor of Medicine (Voluntary)
Washington University in St. Louis

Disclosure(s): No financial relationships to disclose

Slides
Kimberly Scarsi, PharmD

Professor
University of Nebraska Medical Center
Omaha, Nebraska, United States

Disclosure(s): Organon: Grant/Research Support (Ongoing)

Slides
Latesha Elopre, MD (she/her/hers)

Assistant Professor of Medicine
University of Alabama
Birmingham, AL, United States

Disclosure(s): Clinical Care Options: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Health HIV: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Med_IQ: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Merck & Co., Inc.: Grant/Research Support (Ongoing); Merck Sharp & Dohme (MSD): Grant/Research Support (Ongoing); Practice Point: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Robert Wood Johnson: Grant/Research Support (Ongoing); Verywell Medical: Advisor/Consultant (Ongoing), Board Member (Ongoing), Honoraria (Ongoing)

Slides

Disclosure(s):

Colleen F. Kelley, MD, MPH: Gilead Biosciences: Grant/Research Support (Ongoing); Humanigen: Grant/Research Support (Ongoing); Moderna, Inc.: Grant/Research Support (Ongoing); Novavax, Inc.: Grant/Research Support (Ongoing); Viiv Healthcare: Grant/Research Support (Ongoing)

Valeria D. Cantos, M.D: No financial relationships to disclose

Rupa R. Patel, MD MPH: No financial relationships to disclose

Kimberly Scarsi, PharmD: Organon: Grant/Research Support (Ongoing)

Latesha Elopre, MD: Clinical Care Options: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Health HIV: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Med_IQ: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Merck & Co., Inc.: Grant/Research Support (Ongoing); Merck Sharp & Dohme (MSD): Grant/Research Support (Ongoing); Practice Point: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Robert Wood Johnson: Grant/Research Support (Ongoing); Verywell Medical: Advisor/Consultant (Ongoing), Board Member (Ongoing), Honoraria (Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe innovative delivery models for improving PrEP access;
discuss new drugs and delivery systems such as long-acting injectables for PrEP;
recognize and address disparities in PrEP delivery

Presentations:

1:45 PM – 2:10 PM US ET

Innovative Prep Care Models, Implementation and Home Testing
Speaker: Rupa R. Patel, MD MPH (she/her/hers) – Washington University in St. Louis
2:10 PM – 2:35 PM US ET

New Drugs and Delivery Systems
Speaker: Kimberly Scarsi, PharmD – University of Nebraska Medical Center
2:35 PM – 3:00 PM US ET

Equity and Disparities in Prep Delivery
Speaker: Latesha Elopre, MD (she/her/hers) – University of Alabama